1. Introduction {#sec1}
===============

Accurate assessment of triage (a French term meaning "to sort") processes and outcomes is central to any research on emergency department (ED) crowding. Patient volumes and acuity, the aging population, public demands for advanced technology, evidence-based medicine, and payor austerity measures increase pressure on emergency department processes. With increasing demand on EDs and increasing crowding issues, studies must examine factors that influence patient flow. These studies depend on accurate measurements of disease severity and workload. Triage data are used extensively as a proxy for both workload and patient acuity. Thus proper conduct of research into crowding and the ability to apply results across facilities depends on accuracy and reliability of the data.

The five-level Canadian Triage and Acuity Scale (CTAS), using a standardized data element set including a validated Chief Complaint list, has been adopted by the Canadian Association of Emergency Physicians (CAEPs) and National Emergency Nurses Affiliation (NENA) as the standard methodology for emergency department triage \[[@B1]--[@B3]\]. Similar five-level systems are used in the United States, the United Kingdom, and Australia as well as in other jurisdictions. The Canadian Triage and Acuity Scale (CTAS) has been used not only for determining the priority by which patients are evaluated by physicians but also as a proxy for disease severity, nurse and physician workload, a tool in quality improvement processes, and in funding methodologies. Evaluation of the accuracy and reliability of CTAS performance becomes essential for reliable information.

CTAS performance has been measured through representative case evaluation and scoring by triage nurses, indirect measurement of ED statistics comparability between centers, prospective independent scoring in a live environment by duplicated triage staff, and by interobserver reliability studies. CTAS can be performed with very good interobserver reliability and moderately predicts the need for urgent care and resources \[[@B4]--[@B7]\]. Most studies to validate triage scoring are sophisticated double triage prospective designs, are difficult to apply across systems in real life, contain an intrinsic bias toward better performance, use classroom-based testing methods, do not address one or the other of accuracy or reliability, or do not pave the way for outcome-based decisions. In this study we evaluate an inexpensive and easy method to assess CTAS performance in a community emergency department (ED) using (1) a limited set of clinical indicators to allow manageable data analysis, and (2) a nurse reviewer trained in the CTAS National Guidelines (CAEP/NENA). The goal is more reliable performance of the triage function with more predictable effects on outcomes. This in turn would improve the ability to capture variations in systems and better evaluate how crowding influences outcome on a macrosystemic scale. This information ultimately may lead to interventions that improve care and reduce crowding.

2. Methods {#sec2}
==========

The study was approved by the local Research Ethics Committee. Triage in this hospital was routinely performed by an experienced group of ED nurses who had been given CTAS training in the past and had national CTAS Guidelines materials including the CEDIS Chief Complaint list, a validated set of chief complaints for ED triage \[[@B8]\]. An experienced emergency nurse underwent further specific training with CAEP/NENA training materials to become the study\'s nurse reviewer (NR). The NR retrospectively triaged two separate month\'s ED charts one year apart blinded to physician data and triage score. The second data collection was performed one year later to determine the reproducibility of results after staff turnover occurred (approximately 25% of triage staff). Turnover led to the requirement that all triage staff undergo Continuing Education on the CTAS guidelines during the year between the two trials (one-day seminar using the same CAEP/NENA materials and the CEDIS Chief Complaint List).

Inter-observer reliability (IR) was performed between the original charted CTAS score and the NR score. IR results were compared using raw and quadratic weighted Kappa \[[@B4]--[@B7]\] (QuickCalcs by GraphPad Software Inc. 2002--2005). The NR was externally tested for accuracy in the use of the CTAS guidelines using a random case subset and independent review by a Master\'s prepared ED nurse educator (RM) with research experience in CTAS Guidelines (both adults and pediatrics) and inter-observer reliability testing.

Focus groups chose, by consensus, five Indicator Groups for triage performance review that were felt to represent common and clinically important Chief Complaints (CCs). This was done by grouping selected similar CCs from the CEDIS CC list: Chest Pain (adult chest pain cardiac features or noncardiac features from the Cardiovascular list), Headache (Neurological list item), Respiratory Illness (any item from Respiratory CC list), Musculoskeletal Injury (any item from Orthopedic or Trauma Lists), and Performance of the Pain-Scale Modifier when indicated. One data integrity indicator was also chosen and evaluated separately: Insufficient Data (information insufficient to give CTAS score by CTAS guidelines as judged by the NR, e.g., missing historical features or pertinent vital signs). Data were collected in aggregate fashion to test the inclusiveness and performance of the chosen indicators. Multiple indicators were classified as CC \#1, \#2, and \#3. A second CC permitted either CC to include the patient in a count for the appropriate indicator. A second CC was infrequent; there were no charts with 3 CCs. For example, a CC of musculoskeletal injury, upper extremity, with a missing pain-scale would count for both pain-scale indicated but not done and insufficient data for triage, reflecting frequency counts of specific indicator problems.

3. Results {#sec3}
==========

Kappa to establish external validity for the NR compared to the RM was 0.94, or "very good" agreement. There were 2838 patients in Trial 1 and 3091 in Trial 2 ([Table 1](#tab1){ref-type="table"}). The distribution of CTAS scores, rate of Insufficient Data ([Table 2](#tab2){ref-type="table"}), rate of Inconsistent Triage ([Table 3](#tab3){ref-type="table"}), and absolute and weighted Kappa values were similar between the two trials. Weighted (absolute, CI) Kappas for Trial 1 (0.596 (0.48, 95% CI 0.45--0.52)) and for Trial 2 (0.604 (0.49, 95% CI 0.46--0.53)) revealed "moderate" to "good" strength of agreement.

Pain scale was documented in only 1019 (42.8%) and 858 (30.9%) of indicated visits ([Table 4](#tab4){ref-type="table"}). The chosen clinical indicators captured 68% (Trial 1) and 62% (Trial 2) of all patients ([Table 5](#tab5){ref-type="table"}). Of these, 20--65% had insufficient data for triage, with the highest group being Musculoskeletal Injury at 55% and 65%. The rate of inconsistent triage was 14--16% for those charts with sufficient data to perform reviewer CTAS, comparable between the two trial groups ([Table 6](#tab6){ref-type="table"}). The most common reason for inconsistency in CTAS scoring was inappropriate interpretation of the pain scale; missing vital signs was also common (where this error was not sufficient to deem the case as insufficient data to determine a CTAS score by the reviewer ([Table 7](#tab7){ref-type="table"})). Undertriage was more common than overtriage and tended to reflect CTAS 2 and 3 being labeled 3 and 4, respectively. Overtriage tended to reflect CTAS 5 patients being scored as CTAS 4.

4. Discussion {#sec4}
=============

Extra training of the NR to establish the role as a reference standard was successful and produced a very high level of inter-observer agreement (Kappa) with the RM, supporting the NR role as a proxy for CTAS accuracy according to national guidelines. Six key clinical indicators captured over 60% of visits, demonstrating that a small number of easily grouped indicators capture a large proportion of total visits for review. This will allow a nurse reviewer to be trained to perform retrospective chart reviews of triage at a level of complexity easily managed by a community hospital, using simple indicators and the CAEP/NENA training materials.

However, interrater reliability between the NR and the RNs was in the borderline "good" range. Large gaps in data collection were concerning: if data issues are a common occurrence in other EDs, then continuing education efforts need to be directed toward both CTAS guidelines education and compliance. CTAS education and staff turnover did not appear to influence results over time on reliability, rates of insufficient data, and inconsistent triage. Our study may reflect the level of reliability and performance accuracy expected without a persistent, structured effort to improve proficiency \[[@B9]--[@B12]\]. Without a more intensive audit and feedback system CTAS performance remained static. There may be a level of variability in the CTAS for which didactic training is insufficient to generate reliably good performance.

Tendencies toward over- and undertriage likely reflect the phenomenon of "regression toward the mean" \[[@B5], [@B6]\]. New teaching guidelines have recently been released \[[@B13], [@B14]\]; training within a knowledge translation process that includes an emphasis on compliance may be needed to achieve good scale performance (see <http://www.caep.ca/resources>).

Most studies examining CTAS performance have occurred in tertiary care, highly controlled settings, with dual triage observations. Health care facilities in Canada often do not have the funding to pursue sophisticated analysis. This study reviews actual CTAS performance in a community setting, using an easily understood, simple, and inexpensive methodology to measure reliability and a proxy for accuracy. Two major issues were identified giving the information available to the NR: (1) triage scores were inconsistent with CTAS guidelines up to 30% of the time; however (2) incomplete data and missing pain scales in a large percentage of patients were a bigger problem. ED staff must carefully maintain CTAS data quality and compliance with regular training; otherwise one may not reasonably expect CTAS to perform consistently well clinically. This would address the large number of incomplete data cases, which by definition are inaccurate risking clinical error. An analysis of triage variance is not possible in these cases, with the attendant problem of unnecessary practice variability. More capture would better define the K, improve the process of data entry, and hopefully lead to improved interobserver reliability and the standardization of care with better outcomes.

Another issue is the widespread use of Kappa statistics to examine reliability. Despite gaps in triage performance our Kappa values were surprisingly good, revealing the importance of understanding this statistic in context. Multiple measures using specific indicators may actually be superior when evaluating adherence to CTAS guidelines.

One benefit of this method is its simplified grouping of common CCs and the use of a standardized and trained reviewer and process. The same principles could be used to evaluate any triage scale with standardized clinical discriminatory characteristics, well-defined data elements, and a good training manual and approach.

Study limitations included retrospective data collection and lack of a second independent observer for the patient. However, studies using prospective design or a second triage agent could artificially improve accuracy and reliability by improving compliance with study methodology, since staff are aware of the study process. Including patients with insufficient data in the analysis of CTAS inconsistency may not accurately reflect CTAS-scale performance giving appropriate use. However, the purpose was to measure real life staff performance, and an intention to treat review given "best efforts" reflects reality and is less likely to overestimate true performance. While the study tested accuracy through compliance with the CTAS standards, it lacked a true objective measure of accuracy from an outcomes perspective \[[@B13]\]. The ability of the RM to serve as trainer and gold standard was not tested externally or against the newest 2008 CTAS guidelines revision. Accreditation of trainers and expansion to multiple ED settings is desirable.

5. Conclusion {#sec5}
=============

With ED crowding pressure and with limited healthcare resource, hospitals require tools to reliably evaluate patient flow and system performance. CTAS and CEDIS implementation needs an achievable, reliable, and cost effective method for CTAS quality review so that departmental process and outcomes can be improved. We have demonstrated that (1) a small number of simple indicators may capture a large number of cases for review, making standardization simple and easy, (2) a nurse reviewer can be trained to review CTAS Guidelines performance, and (3) basic data compliance with frequent review and feedback may be as important as CTAS education courses for training efforts in a community ED. Further investigation with standardized trainers and audit/feedback loop, and correlation with outcomes is necessary in multiple ED settings.
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###### 

Patient visits by Canadian Triage and Acuity Scale (CTAS) level.

  CTAS visits      Trial 1 patients   Trial 2 patients   Trial 1% in level   Trial 2% In Level
  ---------------- ------------------ ------------------ ------------------- -------------------
  CTAS 1           4                  7                  0.14%               0.23%
  CTAS 2           149                136                5.25%               4.40%
  CTAS 3           1010               1216               35.59%              39.34%
  CTAS 4           1412               1514               49.75%              48.98%
  CTAS 5           219                170                7.72%               5.50%
  Unknown          44                 48                 1.55%               1.55%
                                                                             
  Total patients   2838               3091                                   

###### 

Insufficient data on chart as required by Canadian Triage and Acuity Scale (CTAS) guidelines (% of [Table 1](#tab1){ref-type="table"}).

  CTAS visits                      Trial 1   Trial 2   Trial 1%   Trial 2%
  -------------------------------- --------- --------- ---------- ----------
  CTAS 1                           0         0         0.00%      0.00%
  CTAS 2                           14        23        9.40%      16.91%
  CTAS 3                           302       491       29.90%     40.38%
  CTAS 4                           805       918       57.01%     60.63%
  CTAS 5                           98        79        44.75%     46.47%
  Unknown                          44        48        100.00%    100.00%
                                                                  
  Total having insufficient data   1263      1559      44.50%     50.44%

###### 

Canadian Triage and Acuity Scale (CTAS) level inconsistency compared to nurse reviewer (NR).

  CTAS visits                        Trial 1   Trial 2   Trial 1 % of level   Trial 2 % of level
  ---------------------------------- --------- --------- -------------------- --------------------
  CTAS 1                             1         1         25.00%               14.29%
  CTAS 2                             18        7         12.08%               5.15%
  CTAS 3                             251       227       24.85%               18.67%
  CTAS 4                             242       274       17.14%               18.10%
  CTAS 5                             23        7         10.50%               4.12%
                                                                              
  Total Inconsistent with Reviewer   535       516       18.85%               16.69%

###### 

Pain scale performance when indicated by chief complaint.

  Pain scale done   Trial 1   Trial 2   Trial 1%   Trial 2%
  ----------------- --------- --------- ---------- ----------
  Yes               1019      858       42.8%      30.9%
  Indicated         2382      2774      83.9%      89.7%

###### 

Frequency of the presence of chosen clinical indicator.

  Clinical indicator       Trial 1   Trial 2   Trial 1%   Trial 2%
  ------------------------ --------- --------- ---------- ----------
  Pain                     453       499       16.0%      16.1%
  Chest pain               219       194       7.7%       6.3%
  Musculoskeletal injury   672       777       23.7%      25.1%
  Respiratory illness      527       379       18.6%      12.3%
  Headache                 69        60        2.4%       1.9%
                                                          
  Total indicators found   1940      1909      68.4%      61.8%

###### 

Frequency of clinical indicator Canadian Triage and Acuity Scale (CTAS) inconsistency compared with NR (inconsistency, inconsistency/total: [Table 5](#tab5){ref-type="table"} as %).

  Clinical indicator            Trial 1   Trial 2   Trial 1%   Trial 2%
  ----------------------------- --------- --------- ---------- ----------
  Pain                          71        51        15.7%      10.2%
  Chest pain                    54        38        24.7%      19.6%
  Musculoskeletal pain/injury   91        71        13.5%      9.1%
  Respiratory illness           78        86        14.8%      22.7%
  Headache                      22        18        31.9%      30.0%
                                                               
  Total inconsistent            316       264       16.3%      13.8%
                                                               
  Total indicator patients      1940      1909                 

###### 

Reasons for Canadian Triage and Acuity Scale (CTAS) inconsistency.

  Reason                    Trial 1   Trial 2   Trial 1%   Trial 2%
  ------------------------- --------- --------- ---------- ----------
  Pain scale higher/lower   203       156       32%        25%
  No/improper peak flow     20        2         3%         0%
  Over triage               104       150       17%        24%
  Under triage              208       196       33%        32%
  Missing vital signs       90        110       14%        18%
                                                           
  Total                     627       614                  
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